Emily Schwarz, PhD

Ohio State University
Columbus, Ohio, United States

Presentation(s):

• BP4. Dasatinib reverses myeloid derived suppressor cell (MDSC) inhibition of T-cell proliferation in a triple negative breast cancer model

  Friday, March 6, 2026
  8:23 AM - 8:30 AM MST